Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read More
Therapeutic Modalities

Experiments Link Gut Microbiome and Graft-versus-Host Disease

Modulating the gut microbiome may be a key to preventing GvHD and stopping relapse.
Read More
Autoimmunity & Immunology

Balancing Innovation and Ethics: The Role of Regulation in Microbiome-Based Precision Oncology

Microbiome-based precision oncology offers promising cancer treatment possibilities but requires clear regulations due to ethical concerns like patient safety and access. Collaboration among stakeholders is essential to balance innovation and ethics effectively.
Read More
Therapeutic Modalities

UPenn Medicine Presents Promising Phase I CAR T Trial with Novel Binding Mechanism

The CAR T therapy targets CD19 closer to the cell membrane and has demonstrated remarkable efficacy in its Phase I clinical trial.
Read More
Tumour Microenvironment

Understanding and Overcoming the Immunosuppressive TME

Explore the intricate world of the immunosuppressive tumor microenvironment (TME), a key player in cancer progression and treatment resistance
Read More
Biomarkers in Immuno-Oncology

Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology

Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Read More
Therapeutic Modalities

Immunostimulatory Oncolytic Viruses: Interview with Angelica Loskog, CEO, Lokon Pharma

Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
Read More
Tumour Microenvironment

The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen

Compugen's candidate therapeutic, COM503, targets interleukin-18 binding protein to unleash interleukin-18's immunostimulatory power.
Read More
Tumour Microenvironment

Positive Phase I Data from Oncolytic Virotherapy Trial

TILT-123, an oncolytic virotherapy, has shown promising results from a phase I clinical trial which treats solid tumours in patients that have exhausted other options.
Read More
Therapeutic Modalities

Bispecific Antibody Format: Interview with Laura von Schantz, Chief Technology Officer, Alligator Biosciences

Talking with Laura von Schantz, Chief Technology Officer, at Alligator Biosciences about their RUBY bispecific antibody format.
Read More
Biomarkers in Immuno-Oncology

Translating the Complex Immune System Into Disease Insights With CyTOF Technology

Reasons to choose CyTOF.
Read More
Biomarkers in Immuno-Oncology

NeoGenomics: Connect With Us to Explore How Our Oncology Data and Expertise Can Help Your Team

Data-driven insights from the largest volume cancer-testing lab in the U.S.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno